Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 25
- Q2 2022, −3 vs. previous quarter
- 13F value
- $1.71M
- Reported value at the end of Q2 2022
- Superinvestors holding
- 0
- At the end of Q2 2022
Superinvestors holding ALNA, Q2 2022
No superinvestor reported holding ALNA at the end of Q2 2022.
Latest insider trades
Open-market purchases and sales by Allena Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Brenner Louis MDPresident and CEO | SSale | −40.3K | $0.81 | −$32.7K | −12.3%288.6K after |
Top 10 13F holders, Q2 2022
The largest institutional positions in Allena Pharmaceuticals, Inc. at the end of Q2 2022; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $533.0K | 11.54% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,682,145 | $512.0K | 0.00% | +100,952+3.9% | Added |
| Acadian Asset Management LLC | 1,250,988 | $239.0K | 0.00% | +1,250,988 | New |
| Geode Capital Management, LLC | 386,352 | $73.0K | 0.00% | +50,779+15.1% | Added |
| Two Sigma Securities, LLC | 357,044 | $68.0K | 0.01% | +357,044 | New |
| BlackRock Inc. | 228,215 | $44.0K | 0.00% | −30,705−11.9% | Reduced |
| State Street Corp | 205,058 | $39.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 174,988 | $33.0K | 0.00% | +172,388+6,630.3% | Added |
| Millennium Management LLC | 173,798 | $33.0K | 0.00% | +173,798 | New |
| Kestra Advisory Services, LLC | 164,662 | $31.0K | 0.00% | −8,500−4.9% | Reduced |